Johnson & Johnson (JNJ) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Johnson & Johnson (JNJ) PT Lowered to $135 at Stifel
April 17, 2018 5:09 PM EDTStifel lowered its price target on Johnson & Johnson (NYSE: JNJ) to $135.00 (from $145.00) while maintaining a Hold rating following better-than-expected Q1 but some operational puts and takes.
Analyst Rick Wise commented, "Overall, JNJ 1Q18 results were largely as expected with modest top-line outperformance, better-than-expected... More



